| K-number | K252484 |
| Device name | cobas HCV |
| Applicant | Roche Molecular Systems, Inc. |
| Product code | MZP |
| Device class | Class II |
| Decision date | Nov 3, 2025 |
| Decision | Substantially Equivalent |
| Regulation | 866.3170 |
The FDA summary PDF for this submission is not available in machine-readable form — common for older clearances. View on FDA's site →
View the full FDA submission: accessdata.fda.gov